Anti‐IL‐4Rα mAb (dupilumab) vs placebo (on top of topical steroids)Disease‐specific quality of life · patients with severe chronic rhinosinusitis with nasal polyps1 finding from 1 reviewBiologics for chronic rhinosinusitis 2021 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 784 participantsHigh
Anti‐IgE mAb (omalizumab) vs placebo (on top of topical steroids)Disease‐specific quality of life · patients with chronic rhinosinusitis with nasal polyps1 finding from 1 reviewBiologics for chronic rhinosinusitis 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 265 participantsModerate